Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pacira Pharm Inc (PCRX)

Pacira Pharm Inc (PCRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,664,393
  • Shares Outstanding, K 44,025
  • Annual Sales, $ 429,650 K
  • Annual Income, $ 145,520 K
  • 60-Month Beta 1.10
  • Price/Sales 6.06
  • Price/Cash Flow 26.51
  • Price/Book 4.12
Trade PCRX with:

Options Overview

Details
  • Implied Volatility 48.69%
  • Historical Volatility 33.62%
  • IV Percentile 20%
  • IV Rank 41.38%
  • IV High 76.74% on 02/24/21
  • IV Low 28.88% on 06/02/21
  • Put/Call Vol Ratio 1.15
  • Today's Volume 58
  • Volume Avg (30-Day) 59
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 3,404
  • Open Int (30-Day) 4,254

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.47
  • Number of Estimates 6
  • High Estimate 0.56
  • Low Estimate 0.41
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +1,275.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.77 +2.98%
on 06/11/21
66.99 -9.66%
on 05/24/21
-0.20 (-0.33%)
since 05/11/21
3-Month
58.77 +2.98%
on 06/11/21
74.76 -19.05%
on 03/15/21
-12.48 (-17.10%)
since 03/11/21
52-Week
40.96 +47.75%
on 06/15/20
80.00 -24.35%
on 02/25/21
+17.99 (+42.30%)
since 06/11/20

Most Recent Stories

More News
Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021

-- EXPAREL average daily sales for May 2021 were 162% of May 2020 --

PCRX : 60.52 (+2.26%)
How Has PCRX Performed 30 Days Post Earnings

Pacira (PCRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PCRX : 60.52 (+2.26%)
Pacira BioSciences Announces Top-line Results from Phase 3 STRIDE Study Evaluating EXPAREL as a Lower Extremity Nerve Block

-- Study did not demonstrate statistical significance for primary endpoint of pain reduction from 0 to 96 hours for EXPAREL versus bupivacaine HCl --

PCRX : 60.52 (+2.26%)
Pacira BioSciences to Present at the 2021 Jefferies Virtual Healthcare Conference

Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 Jefferies Virtual Healthcare Conference at 9:30 AM ET on Tuesday, June 1, 2021. Live audio of the virtual event...

PCRX : 60.52 (+2.26%)
Pacira BioSciences Announces Notice of Allowance of New Patent for EXPAREL

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that the United States Patent and Trademark...

PCRX : 60.52 (+2.26%)
Pacira BioSciences to Present at the 2021 RBC Capital Markets Global Healthcare Conference

Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 RBC Capital Markets Global Healthcare Conference at 10:20 AM ET on Tuesday, May 18, 2021. Live audio of the virtual...

PCRX : 60.52 (+2.26%)
Pacira BioSciences Reports Preliminary Net Product Sales of $44.6 Million for April 2021

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited net product sales of...

PCRX : 60.52 (+2.26%)
Deciphera (DCPH) Q1 Loss Narrower Than Expected, Revenues Beat

Deciphera (DCPH) posts a narrower loss in the first quarter while sales beat on the encouraging uptake of Qinlock.

IRWD : 11.73 (-0.34%)
PFE : 40.15 (-1.30%)
PCRX : 60.52 (+2.26%)
DCPH : 35.42 (+3.36%)
Bausch's (BHC) Q1 Earnings Beat Estimates, Revenues Miss

Bausch (BHC) beats on earnings but misses on sales in the first quarter due to the ongoing pandemic.

IRWD : 11.73 (-0.34%)
PCRX : 60.52 (+2.26%)
NBRV : 1.4400 (-1.37%)
BHC : 31.82 (+0.82%)
Esperion (ESPR) Q1 Earnings Miss, Lower Drug Price Hits Sales

Esperion Therapeutics (ESPR) reports dismal first-quarter results as it misses estimates for earnings and sales. Stock down.

IRWD : 11.73 (-0.34%)
MRK : 76.27 (+0.17%)
PCRX : 60.52 (+2.26%)
ESPR : 26.37 (+3.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc....

See More

Key Turning Points

3rd Resistance Point 62.87
2nd Resistance Point 61.70
1st Resistance Point 61.11
Last Price 60.52
1st Support Level 59.35
2nd Support Level 58.18
3rd Support Level 57.59

See More

52-Week High 80.00
Fibonacci 61.8% 65.09
Last Price 60.52
Fibonacci 50% 60.48
Fibonacci 38.2% 55.87
52-Week Low 40.96

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar